Dima Biology Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Dima Biology General Information

Description

Developer of monoclonal antibody technology designed to create tumor immunology products and services. The company utilizes digital monoclonal antibody technology and specializes in the development of recombination monoclonal antibodies, enabling patients and medical institutions to enjoy quality antibodies to treat tumor diseases.

Contact Information

Website
www.dimabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 411-9, Building 2
  • No. 8 Jinfeng Road, Gaoxin District
  • Suzhou, Jiangsu 215163
  • China
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Unit 411-9, Building 2
  • No. 8 Jinfeng Road, Gaoxin District
  • Suzhou, Jiangsu 215163
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dima Biology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 26-Jan-2022 Completed Startup
1. Seed Round 11-Sep-2019 Completed Startup
To view Dima Biology’s complete valuation and funding history, request access »

Dima Biology Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Dima Biology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4582449-A1 Recombinant humanized monoclonal antibody targeting human gprc5d and application thereof Pending 30-Aug-2022
US-20260028398-A1 Recombinant humanized monoclonal antibody targeting human gprc5d and application thereof Pending 30-Aug-2022
WO-2024046239-A1 Recombinant humanized monoclonal antibody targeting human gprc5d and application thereof Inactive 30-Aug-2022 C07K16/28

Dima Biology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Emerging Technology Partners (Venture Capital) Venture Capital Minority
HeavyBio Corporation Minority
OPM Biosciences Corporation Minority
Guoqian Venture Capital Venture Capital Minority
Huatai Zijin Investment Corporate Venture Capital Minority
To view Dima Biology’s complete investors history, request access »

Ready to get started?

Request a free trial

Dima Biology FAQs

  • When was Dima Biology founded?

    Dima Biology was founded in 2019.

  • Where is Dima Biology headquartered?

    Dima Biology is headquartered in Suzhou, China.

  • What industry is Dima Biology in?

    Dima Biology’s primary industry is Biotechnology.

  • Is Dima Biology a private or public company?

    Dima Biology is a Private company.

  • What is Dima Biology’s current revenue?

    The current revenue for Dima Biology is .

  • Who are Dima Biology’s investors?

    Emerging Technology Partners (Venture Capital), HeavyBio, OPM Biosciences, Guoqian Venture Capital, and Huatai Zijin Investment have invested in Dima Biology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process